why choose us

300×250 Ad Slot

Research Article: Post-Acute SARS-CoV- Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection

Date Published: 2023-04-24

Introduction:
Many with post-acute SARS-CoV- (PASC) have persistent symptoms impacting physical and cognitive function, decreased health and health-related life quality, and is of global concern. – Monoclonal antibody (mAb) treatment was available in the early phase of the pandemic starting in to treat acutely infected patients to improve survival as well as possible PASC sequelae.

Read more

300×250 Ad Slot